Table 3

- The prevalence of MteS components among participants, according to IDF/ AHA/NHLBI criteria.

ComponentTotal (300)Female (165)Male (135)P-value
n%n%n%
020.60021.50.117
16220.7159.14734.8<0.001**
211237.36740.64533.30.196
39832.76740.631230.001*
4268.7169.7107.40.484

*significant (<0.05), **significant (<0.001)